Verona Pharma PLC ADR
Price & Volume
Stats
See more52W Range | $11.39-$70.40 |
Market Cap | $8.8B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $42.2M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $39.6M |
Diluted EPS | -$2.16 |
News
See moreYahoo Finance • 27 days ago
Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Yahoo Finance • last month
Verona Pharma Announces March 2025 Investor Conference Participation
Yahoo Finance • last month
Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update
Yahoo Finance • last year
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital
About
CEO | Dr. David S. Zaccardelli Pharm.D. |
Address | 3 More London Riverside, London, United Kingdom, SE1 2RE |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 209 |
